Co-treatment of Brazilein Enhances Cytotoxicity of Doxorubicin on WiDr Colorectal Cancer Cells Through Cell Cycle Arrest
Abstract
BACKGROUND: The presence of adverse side effects limits the use of doxorubicin (Dox) despite its cost-effectiveness compared to other chemotherapeutic agents. Brazilein (Be), the major compound of Caesalpinia sappan, performs co-chemotherapeutic potency in several cancer cell lines. This study evaluates the chemosensitizing effects of Be to Dox on colon cancer cell line, WiDr.
METHODS: The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay was conducted to evaluate the cytotoxic effect of Be and its combination with Dox. The synergistic effect of Be and Dox was examined by using the Combination index (CI) parameter. Cell cycle and apoptosis profiles were done using flow cytometry with propidium iodide (PI)/RNase and Annexin V staining, respectively.
RESULTS: The combination of Dox and Be at half of IC50 on WiDr cells showed a synergistic effect with a combination index of 0.4. Analysis of the cell cycle revealed that the combination caused cell cycle termination at the S and G2/M phase. This finding corresponded with the data that single treatment of Dox and Be induced cell cycle arrest at the different phases, namely S and G2/M phase, respectively. However, the combination treatment for 24 hours did not induce apoptosis. This combination should be further clarified as there was a possibility that many cells may underwent permanently arrest that halts to proceed apoptosis.
CONCLUSION: Our findings suggested that Be synergizes with Dox to suppress the growth of WiDr cells via cell cycle arrest, hence, Be is potential to be developed as a co-chemotherapeutic agent. Our findings suggested that Be synergizes with Dox to suppress the growth of WiDr cells via cell cycle arrest, hence, Be is potential to be developed as a co-chemotherapeutic agent.
KEYWORDS: Brazilein, colon cancer WiDr, co-treatment, Doxorubicin, cell cycle arrest
Full Text:
PDFReferences
Taymaz-Nikerel H, Karabekmez ME, Eraslan S, Kırdar B. Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cells. Sci Rep. 2018; 8: 1–14, CrossRef.
Hu T, Li Z, Gao CY, Cho CH. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World J Gastroenterol. 2016; 22: 6876–89, CrossRef.
Sonowal H, Pal PB, Wen JJ, Awasthi S, Ramana K V., Srivastava SK. Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity. Sci Rep. 2017; 7: 1–14, CrossRef.
Mokhtari RB, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, et al. Combination therapy in combating cancer. Oncotarget. 2017; 8: 38022–43, CrossRef.
Zhang QY, Wang FX, Jia KK, Kong LD. Natural product interventions for chemotherapy and radiotherapy-induced side effects. Front Pharmacol. 2018; 9: 1253, CrossRef.
Rejhová A, Opattová A, Čumová A, Slíva D, Vodička P. Natural compounds and combination therapy in colorectal cancer treatment. Eur J Med Chem. 2018; 144: 582–94, CrossRef.
Lim KH, Han SW, Oh DY, Im SA, Kim TY, Bang YJ. Outcome of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) chemotherapy and analysis of prognostic factors in patients with refractory advanced biliary tract cancer. Oncol. 2012; 83: 57–66, CrossRef.
Khasraw M, Bell R, Dang C. Epirubicin: Is it like doxorubicin in breast cancer? A clinical review. Breast. 2012; 21: 142–9, CrossRef.
Nirmal NP, Rajput MS, Prasad RGSV, Ahmad M. Brazilin from Caesalpinia sappan heartwood and its pharmacological activities: A review. Asian Pac J Trop Med. 2015; 8: 421–30, CrossRef.
Handayani S, Susidarti RA, Jenie RI, Meiyanto E. Two active compounds from Caesalpinia sappan L. in combination with cisplatin synergistically induce apoptosis and cell cycle arrest on WiDr cells. Adv Pharm Bull. 2017; 7: 375–80, CrossRef.
Rachmady R, Muntafiah L, Rosyadi F, Sholihah I, Handayani S, Jenie RI. Antiproliferative effect of secang heartwood ethanolic extract (Caesalpinia sappan L.) on HER2-positive breast cancer cells. Indones J Cancer Chemoprevention. 2017; 7: 1–5, CrossRef.
Handayani S, Susidarti RA, Udin Z, Meiyanto E, Jenie RI. Brazilein in combination with cisplatin inhibit proliferation and migration on highly metastatic cancer cells, 4T1. Indones J Biotechnol. 2016; 21: 38–47, CrossRef.
Jenie RI, Handayani S, Susidarti RA, Udin LZ, Meiyanto E. The cytotoxic and antimigratory activity of Brazilin-doxorubicin on MCF-7/HER2 cells. Adv Pharm Bull. 2018; 8: 507–16, CrossRef.
Hsieh CY, Tsai PC, Chu CL, Chang FR, Chang L Sen, Wu YC, et al. Brazilein suppresses migration and invasion of MDA-MB-231 breast cancer cells. Chem Biol Interact. 2013; 204: 105–15, CrossRef.
Utomo RY, Novarina A, Tirtanirmala P, Kastian RF, Jenie RI. Enhancement of cytotoxicity and apoptosis induction of Doxorubicin by Brazilein containing fraction of secang (Caesalpinia sappan L.) on T47D Cells. Indones J Cancer Chemoprevention. 2018; 9: 32–40, CrossRef.
Li WL, Zheng HC, Bukuru J, De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol. 2004; 92: 1–21, CrossRef.
Meiliana A, Dewi NM, Wijaya A. Red meats and processed meat as the carcinogenic foods and phytochemical-chemoprevention. Indones Biomed J. 2019; 11: 225-39, CrossRef.
Meiliana A, Dewi NM, Wijaya A. The immunobiology of cancer: an update review. Indones Biomed J. 2017; 9: 53-72, CrossRef.
Van Der Jeught K, Xu HC, Li YJ, Lu X Bin, Ji G. Drug resistance and new therapies in colorectal cancer. World J Gastroenterol. 2018; 24: 3834–48, CrossRef.
Strum WB. Unrequited returns in asymptomatic colorectal cancer detection. Clin Surg. 2018; 3: 1995, article.
Nurgali K, Jagoe RT, Abalo R. Editorial: Adverse effects of cancer chemotherapy: Anything new to improve tolerance and reduce sequelae? Front Pharmacol. 2018; 9: 1–3. , CrossRef.
Pretzsch E, Bösch F, Neumann J, Ganschow P, Bazhin A, Guba M, et al. Mechanisms of metastasis in colorectal cancer and metastatic organotropism: hematogenous versus peritoneal spread. Journal of oncology. 2019; 2019: 7407190, CrossRef.
Liang CH, Chan LP, Chou TH, Chiang FY, Yen CM, Chen PJ, et al. Brazilein from Caesalpinia sappan L. antioxidant inhibits adipocyte differentiation and induces apoptosis through caspase-3 activity and anthelmintic activities against Hymenolepis nana and Anisakis simplex. Evid Based Complementary Alter. Med. 2013; 2013: 864892, CrossRef.
Shen J, Zhang H, Lin H, Su H, Xing D, Du L. Brazilein protects the brain against focal cerebral ischemia reperfusion injury correlating to inflammatory response suppression. Eur J Pharmacol. 2007; 558: 88–95, CrossRef.
Kim YS, Ahn YH, Song KJ, Kang JG, Lee JH, Jeon SK, et al. Overexpression and β-1,6-N-Acetylglucosaminylation-initiated aberrant glycosylation of TIMP-1: A “double whammy” strategy in colon cancer progression. J Biol Chem. 2012; 287: 32467–78, CrossRef.
Linda Laksmiani NP, Asmah Susidarti R, Meiyanto E. Brazilein increases the sensitivity of doxorubicin on MCF-7 resistant doxorubicin (MCF-7/DOX) cells through inhibition of HER-2 activation. Int J Pharm Pharm Sci. 2015; 7: 525–8, article.
Wulandari N, Meiftasari A, Fadliyah H, Jenie RI. Red betel leaves methanolic extract (Piper crocatum Ruiz & Pav.) increases cytotoxic effect of Doxorubicin on WiDr colon cancer cells through apoptosis induction. Indones J Cancer Chemoprev. 2018; 9(1): 1–8, CrossRef.
Warkhade AA, Awad AH, Bhagat A, Karuppayil SM. Synergistic activation of Doxorubicin against cancer: A review. Am J Clin Microbiol Antimicrob. 2018; 1: 1009. Synergistic activation of Doxorubicin against cancer: A review. Am J Clin Microbiol Antimicrob. 2018; 1: 1009, article.
Xiong S, Xiao GW. Reverting doxorubicin resistance in colon cancer by targeting a key signaling protein, steroid receptor coactivator. Exp Ther Med. 2018; 15: 3751–8, CrossRef.
Meiyanto E, Larasati YA. The chemopreventive activity of Indonesia medicinal plants targeting on hallmarks of cancer. Adv Pharm Bull. 2019; 9: 219–30, CrossRef.
Meiyanto E, Lestari B, Sugiyanto RN, Jenie RI, Utomo RY, Sasmito E, et al. Caesalpinia sappan L. heartwood ethanolic extract exerts genotoxic inhibitory and cytotoxic effects. Orient Pharm Exp Med. 2019; 19: 27–36, CrossRef.
Anders CK, Adamo B, Karginova O, Deal AM, Rawal S, Darr D, et al. Pharmacokinetics and efficacy of PEGylated liposomal Doxorubicin in an intracranial model of breast cancer. PLoS One. 2013; 8: e61359, CrossRef.
Taymaz-Nikerel H, Karabekmez ME, Eraslan S, Kırdar B. Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cells. Sci Rep. 2018; 8: 1–4, CrossRef.
Sireeratawong S, Piyabhan P, Singhalak T, Wongkrajang Y, Temsiririrkkul R, Punsrirat J, et al. Toxicity evaluation of sappan wood extract in rats. J Med Assoc Thai. 2011; 93: S50–7, PMID.
Athinarayanana G, Ranjitsingh AJ, Padmalatha C. Toxicological studies of Caesalpinia sappan wood derived dye in Wister albino rats. Food Science and Human Wellness. 2017; 6: 34–8, CrossRef.
DOI: https://doi.org/10.18585/inabj.v12i4.1293
Copyright (c) 2020 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
